NDC 52891-103-01 - DR. OBERON NATURAL BABY
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 52891-103
- Requested NDC
- 52891-103-01
- Package NDCs from labels
- 52891-103-01, 52891-103-02
- Manufacturer
- Oberon Cosmetic Co., Ltd.
- Effective date
- 2014-06-29
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| DR. OBERON NATURAL BABY LOTION | Oberon Cosmetic Co., Ltd. | 2014-06-29 | HUMAN OTC DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 52891-103-02 | 2019-11-27 | C162847 | 48780-1 | 9855e2a2-4dcd-60a7-e053-dbdaa90a05bd | DR. OBERON NATURAL BABY LOTION |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 52891-103-01 | DR. OBERON NATURAL BABY | 50 mL in 1 TUBE | LOTION | 50 | 2 | |
| 52891-103-02 | DR. OBERON NATURAL BABY | 1 in 1 CARTON | LOTION | 1 | 2 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Artificial Tears Lubricant Eye Drops | GLYCERIN, PROPYLENE GLYCOL | CVS Pharmacy | 28297fee-8185-4869-8f39-5bfbf8bf8bfd | 2026-04-13 | Warnings | PDC6A3C0OX |
| blink boost | GLYCERIN | Bausch & Lomb Incorporated | e765c224-1718-488f-99b2-976eb60c1d63 | 2026-04-13 | Warnings | PDC6A3C0OX |
| Hemorrhoidal Cream with Lidocaine | GLYCEROL, PHENYLEPHINE, PRAMOXINE, PETROLATUM | Trifecta Pharmaceuticals Usa Llc | 4f1ef866-c4af-989b-e063-6294a90a148e | 2026-04-10 | Warnings | PDC6A3C0OX |
| WE FRESH Lubricating Eye Drops | GLYCERIN | Oculus Surgical, Inc. | 4f253b5d-001b-091e-e063-6394a90a9d39 | 2026-04-09 | Warnings | PDC6A3C0OX |
| Sore Throat | PHENOL GLYCERIN | Walgreens | 1e845299-178e-49ce-9d08-7e9d548a5a6d | 2026-04-09 | Warnings | PDC6A3C0OX |
| Thera Plus Hemorrhoidal | GLYCERIN, PHENYLEPHRINE HYDROCHLORIDE, PRAMOXINE HYDROCHLORIDE, WHITE PETROLATUM | Fourstar Group USA, Inc. | 5d63bf97-29d2-4c71-97c3-85f425e86207 | 2026-04-07 | Warnings | PDC6A3C0OX |
| Hair GrowthShampoo | HAIR GROWTH SHAMPOO | Guangzhou Ariel Biotech Co., Ltd. | 4ed5ac44-44d3-7ed9-e063-6294a90a6614 | 2026-04-06 | Warnings | WV9CM0O67Z |
| Pancreaplex | CHELIDONIUM MAJUS, GLYCYRRHIZA GLABRA, NUX MOSCHATA, RHEUM (PALMATUM), SYZYGIUM JAMBOLANUM, TARAXACUM OFFICINALE, ZINGIBER OFFICINALE, HYDRASTIS CANADENSIS, GLANDULA SUPRARENALIS SUIS, HEPAR SUIS, HYPOPHYSIS SUIS, PANCREAS SUIS, THYROIDINUM (SUIS), PHASEOLUS, PHOSPHORICUM ACIDUM, PHOSPHORUS | BioActive Nutritional, Inc. | 4f7fbb76-79c0-4c1e-aa30-a39492db63d8 | 2026-04-03 | Warnings | 2788Z9758H |
| KIDS TOOTHPASTE, FOR CAVITY PROTECTION | KIDS TOOTHPASTE FOR CAVITY PROTECTION | Shulisa (Foshan) Daily ChemicalIndustry Co., Ltd | 4e8fab9e-f05c-5e2f-e063-6294a90aecf9 | 2026-04-03 | Warnings | 059QF0KO0R |
| Cold Sore Formula | DULCAMARA, GLYCYRRHIZA GLABRA, RANUNCULUS BULBOSUS, RHUS TOX, NATRUM MURIATICUM, FAGOPYRUM ESCULENTUM, NATRUM MURIATICUM, ACONITUM NAPELLUS, CYTOMEGALOVIRUS NOSODE, HERPES SIMPLEX I AND II NOSODE, SEPIA, EPSTEIN BARR VIRUS NOSODE, HERPES ZOSTER NOSODE, ADENOVIREN NOSODE | Nutritional Specialties, Inc. | f4e7e469-baaf-4c61-af44-80b0832eadf0 | 2026-03-31 | Warnings | 2788Z9758H |
| Target Advanced Scar Gel | ADVANCED SCAR GEL | Target Corporation | 86c215fe-aad4-45d1-bdb7-cde00a115c5c | 2026-03-31 | Warnings | 344S277G0Z |
| Cold Sore Formula | DULCAMARA, GLYCYRRHIZA GLABRA, RANUNCULUS BULBOSUS, RHUS TOX, NATRUM MURIATICUM, FAGOPYRUM ESCULENTUM, NATRUM HYPOCHLOROUS, ACONITUM NAPELLUS, CYTOMEGALOVIRUS NOSODE, HERPES SIMPLEX I AND II NOSODE, SEPIA, EPSTEIN BARR VIRUS NOSODE, HERPES ZOSTER NOSODE, ADENOVIREN NOSODE | Nutritional Specialties, Inc. | ad6a08ec-5eba-405b-8a07-79ac86ab3e7a | 2026-03-31 | Warnings | 2788Z9758H |
| Redness Relief | GLYCERIN, NAPHAZOLINE HCL | Pharmadel LLC | 4c113bb9-814f-d92d-e063-6294a90a8302 | 2026-03-30 | Warnings | PDC6A3C0OX |
| Prostazen | ENLARGED PROSTATE, PROSTATIC UTRICLE FUNCTION, AND PROSTATITIS RECOVERY | HCBIOPHARM LLC | d16bc0cb-b9a6-9a24-e053-2995a90a7cd4 | 2026-03-30 | Warnings | 7TRV45YZF7 |
| Moisture Oyster | GLYCERIN | Moisture Oyster Inc | 4e45317a-437f-4d88-e063-6294a90a98d0 | 2026-03-30 | Warnings | PDC6A3C0OX |
| Endoplex F | CIMICIFUGA RACEMOSA, FUCUS VESICULOSUS, GLYCYRRHIZA GLABRA, XANTHOXYLUM FRAXINEUM, ADRENALINUM, CEREBRUM SUIS, HYPOPHYSIS SUIS, HYPOTHALAMUS (SUIS), OOPHORINUM (SUIS), PINEAL (SUIS), THYROIDINUM (SUIS), PULSATILLA (VULGARIS), SEPIA | BioActive Nutritional, Inc. | bfe6d42a-a3e5-44b3-ab8f-b08ad4e2b66f | 2026-03-30 | Warnings | 2788Z9758H |
| Aveeno Skin Relief Healing | GLYCERIN | Kenvue Brands LLC | 345fdde5-700b-7103-e063-6394a90a0e3e | 2026-03-27 | Warnings | PDC6A3C0OX |
| Cerebraplex | AVENA SATIVA, CAPSICUM ANNUUM, GINKGO BILOBA, HYDROCOTYLE ASIATICA, POLYGONUM MULTIFLORUM, ROSMARINUS OFFICINALIS, VINCA MINOR, CEREBRUM SUIS, BARYTA CARBONICA, BELLADONNA, GERMANIUM SESQUIOXIDE, KALI PHOSPHORICUM, STRAMONIUM | BioActive Nutritional, Inc. | 38905213-f20b-45d5-8e65-5f32e3839ea7 | 2026-03-27 | Warnings | 7M867G6T1U |
| Crocodile Tears Lubricant Eye Drops | GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400 | Crocodile Tears LLC | 4df29336-ea0c-0484-e063-6294a90a685a | 2026-03-26 | Warnings | PDC6A3C0OX |
| Artificial Tears Lubricant Eye Drops | GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400 | KC Pharmaceuticals, Inc | 4de5c844-85ca-ff9f-e063-6394a90ac12c | 2026-03-25 | Warnings | PDC6A3C0OX |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.